22
Quantified Imaging has signed its first commercial agreement with mediri GmbH to work on blood-brain barrier (BBB) ASL imaging for clinical trials. With their background in advanced MRI and data management, mediri are the perfect partner for this project and we look forward to advancing this exciting new imaging technique with our world-leading quantification tools.